Cargando…
Nrf2 as a novel diagnostic biomarker for papillary thyroid carcinoma
Papillary thyroid carcinoma (PTC) is the most common thyroid malignancy. However, it is very difficult to distinguish PTC from benign carcinoma. Thus, specific diagnostic biomarkers are actively pursued. Previous studies observed that Nrf2 was highly expressed in PTC. Based on this research, we hypo...
Autores principales: | Wang, Zhiyang, Li, Jing, Liu, Ziwei, Yue, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080292/ https://www.ncbi.nlm.nih.gov/pubmed/36951264 http://dx.doi.org/10.4081/ejh.2023.3622 |
Ejemplares similares
-
Insight of novel biomarkers for papillary thyroid carcinoma through multiomics
por: Liu, Wei, et al.
Publicado: (2023) -
ADORA1 is a diagnostic-related biomarker and correlated with immune infiltrates in papillary thyroid carcinoma
por: Lin, Xu, et al.
Publicado: (2021) -
Identification of Potential lncRNAs and miRNAs as Diagnostic Biomarkers for Papillary Thyroid Carcinoma Based on Machine Learning
por: Yang, Fei, et al.
Publicado: (2021) -
Discovery and identification of potential biomarkers of papillary thyroid carcinoma
por: Fan, Yuxia, et al.
Publicado: (2009) -
Identification of novel diagnostic biomarkers for thyroid carcinoma
por: Wang, Xiliang, et al.
Publicado: (2017)